Marc Uknis, M.D.

Vice President Development

Dr. Uknis joined Achillion in 2018 as development leader for C3G programs. Dr. Uknis joined the industry full time more than ten years ago and has held postions of increasing responsibility with ViroPharma, ViroPharma/Shire and CSL Behring. At each of those companies, he led clinical development programs for complement inhibition in rare diseases, gaining alignment with Regulatory Authorities for multiple accelerated approval developmental programs. Dr. Uknis also holds a Master’s Degree in Business Administration from George Washington University and is a fellow of the American College of Surgeons.

He was trained in transplant surgery at the University of Minnesota and performed hundreds of kidney, liver, pancreas and small intestine transplants as head of programs at Harvard and then University of Massachusetts Medical School where he still holds an adjunct professorship in Molecular Genetics and Microbiology.